Recursion Pharmaceuticals
RXRX
#5083
Rank
C$2.52 B
Marketcap
C$4.05
Share price
3.86%
Change (1 day)
-30.42%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2026 (TTM): C-$1.26

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C-$1.29. In 2025 the company made an earnings per share (EPS) of C-$2.12 an increase over its 2024 EPS that were of C-$2.38.

EPS history for Recursion Pharmaceuticals from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$1.26-40.5%
2025C-$2.12-10.84%
2024C-$2.385.73%
2023C-$2.2514.6%
2022C-$1.9617.39%
2021C-$1.67